# High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer

> **NCT00004150** · PHASE3 · COMPLETED · sponsor: **Robert Roessle Klinik**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00004150
- **Lead sponsor:** Robert Roessle Klinik
- **Sponsor class:** INDIV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004150, "High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00004150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*